Back to search

Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex

Data up to Jan 2025

Published1996
Citations94
References71

Total Citations Per Year

Abstract

References (71)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

A New Clinical Scale for the Staging of Dementia

1982 • 6,699 citations

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

1991 • 4,669 citations

Diagnosis of Alzheimer's Disease

1985 • 2,482 citations

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1978 • 2,036 citations

Neuronal NADPH diaphorase is a nitric oxide synthase.

1991 • 1,917 citations

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

1991 • 889 citations

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1980 • 866 citations

Selective Sparing of a Class of Striatal Neurons in Huntington's Disease

1985 • 767 citations

Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical Development

1993 • 660 citations

NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE

1977 • 490 citations

Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.

1984 • 481 citations

NADPH‐diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin‐ and avian pancreatic polypeptide (APP)‐like immunoreactivities

1983 • 426 citations

Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

1992 • 371 citations

Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide

1984 • 366 citations

ALZHEIMER'S PRESENILE DEMENTIA, SENILE DEMENTIA OF ALZHEIMER TYPE AND DOWN'S SYNDROME IN MIDDLE AGE FORM AN AGE RELATED CONTINUUM OF PATHOLOGICAL CHANGES

1984 • 344 citations

Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile Dementia of the Alzheimer type

1981 • 274 citations

Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects alzheimer‐type dementia

1987 • 252 citations

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

1986 • 251 citations

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

1983 • 223 citations

Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in alzheimer's disease

1988 • 219 citations

Neuropeptides in Alzheimer type dementia

1983 • 214 citations

Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons

1984 • 203 citations

Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of broca to dorsal hippocampus, cingulate cortex and olfactory bulb: A combined wheatgerm agglutinin-apohorseradish peroxidase-gold immunohistochemical study

1989 • 199 citations

Peptides, the limbic lobe and schizophrenia

1983 • 184 citations

Relative sparing of nitric oxide synthase–containing neurons in the hippocampal formation in Alzheimer's disease

1992 • 175 citations

Immunohistochemical markers in rat cortex: co-localization of calretinin and calbindin-D28k with neuropeptides and GABA

1992 • 174 citations

Strong Inference, Theory Testing, and the Neuroanatomy of Schizophrenia

1993 • 164 citations

Corticotropin-Releasing Factor-like Immunoreactivity in Senile Dementia of the Alzheimer Type

1985 • 161 citations

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease

1986 • 155 citations

Neurochemistry and Neuroendocrinology of Schizophrenia: A Selective Review

1993 • 149 citations

II. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's‐type dementia

1985 • 146 citations

Cortical Substance P‐Like Immunoreactivity in Cases of Alzheimer's Disease and Senile Dementia of the Alzheimer Type

1982 • 141 citations

Ventral mesencephalic neurons containing both cholecystokinin‐ and tyrosine hydroxylase‐like immunoreactivities project to forebrain regions

1989 • 139 citations

Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide

1980 • 128 citations

Neuropeptides in the cerebral circulation.

1989 • 126 citations

Neuropeptides in Alzheimer's disease, depression and schizophrenia

1981 • 119 citations

Alzheimer's disease

1987 • 103 citations

Severe cognitive impairment in elderly schizophrenic patients: A clinicopathological study

1993 • 102 citations

Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia

1984 • 101 citations

Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics

1991 • 96 citations

Ultrastructural analysis of somatostatin‐immunoreactive neurons and synapses in the temporal and occipital cortex of the macaque monkey

1989 • 91 citations

Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia

1984 • 84 citations

Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type

1981 • 79 citations

Somatostatin- and Neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of alzheimer's type

1986 • 78 citations

Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type

1986 • 76 citations

CSF somatostatin‐like immunoreactivity in dementia

1986 • 74 citations

NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease

1992 • 68 citations

Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type

1989 • 67 citations

Galanin-Like Immunoreactivity Is Increased in the Postmortem Cerebral Cortex from Patients with Alzheimer's Disease

1994 • 58 citations

Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: An immunohistochemical study

1986 • 54 citations

An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions

1986 • 54 citations

Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex

1991 • 49 citations

Cholecystokinin peptides, dopamine and schizophrenia — A review

1985 • 49 citations

Human cerebrospinal fluid somatostatin in neurologic disease

1985 • 48 citations

Paucity of glutaminase‐immunoreactive nonpyramidal neurons in the rat cerebral cortex

1992 • 44 citations

Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment

1993 • 38 citations

Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex

1993 • 37 citations

Morphology and distribution of neuropeptide-containing neurons in human cerebral cortex

1992 • 37 citations

Distribution of Neuropeptide Y, C-Terminal Flanking Peptide of NPY and Galanin and Coexistence with Catecholamine in the Locus coeruleus of Normal Human, Alzheimer's Dementia and Parkinson's Disease Brains

1990 • 37 citations

A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease

1990 • 35 citations

Distribution of GABA and neuropeptides in the human cerebral cortex

1991 • 33 citations

Effect of haloperidol on immunoreactive neuropeptide Y in rat cerebral cortex and basal ganglia

1990 • 25 citations

Corticotropin-releasing factor immunoreactive neurons persist throughout the brain in Alzheimer's disease

1989 • 25 citations

Decreased somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic schizophrenic patients with cognitive impairment

1990 • 25 citations

Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes

1988 • 23 citations

Somatostatin and cognitive functions in Alzheimer's disease — the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine

1991 • 21 citations

Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia

1987 • 19 citations

The emergence of the cortical GABAergic neuron: with particular reference to some peptidergic subpopulations

1993 • 9 citations

Effect of haloperidol withdrawal on somatostatin level and binding in rat brain

1990 • 9 citations

The presence of neuropeptides in GABAergic and cholinergic rat cerebrocortical synaptosome sub-populations

1992 • 6 citations

Cited By (0)

No citing papers found in database

Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex (1996) – Biological Psychiatry | Metascience Observatory Explorer